Syra Health Corp.
SYRA
$0.07
-$0.01-11.19%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.09% | -1.19% | 6.02% | 13.62% | 42.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.09% | -1.19% | 6.02% | 13.62% | 42.50% |
| Cost of Revenue | -28.49% | -26.33% | -12.67% | 31.01% | 54.36% |
| Gross Profit | -17.03% | 115.11% | 96.53% | -21.75% | 20.52% |
| SG&A Expenses | -24.72% | -46.00% | -29.93% | -27.43% | 17.13% |
| Depreciation & Amortization | -78.82% | -65.52% | -45.60% | -41.13% | 105.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.41% | -40.20% | -27.07% | -8.86% | 39.38% |
| Operating Income | 45.86% | 95.45% | 67.22% | 49.13% | -25.04% |
| Income Before Tax | 45.89% | 95.43% | 67.36% | 49.32% | -17.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.89% | 95.43% | 67.36% | 49.32% | -17.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.89% | 95.43% | 67.36% | 49.32% | -17.80% |
| EBIT | 45.86% | 95.45% | 67.22% | 49.13% | -25.04% |
| EBITDA | 43.78% | 95.83% | 67.41% | 49.23% | -21.98% |
| EPS Basic | 67.13% | 97.48% | 81.69% | 67.16% | 29.27% |
| Normalized Basic EPS | 67.13% | 97.49% | 81.68% | 67.21% | 29.33% |
| EPS Diluted | 67.13% | 97.48% | 81.69% | 67.16% | 29.27% |
| Normalized Diluted EPS | 67.13% | 97.49% | 81.68% | 67.21% | 29.33% |
| Average Basic Shares Outstanding | 64.34% | 80.83% | 78.39% | 54.44% | 66.61% |
| Average Diluted Shares Outstanding | 64.34% | 80.83% | 78.39% | 54.44% | 66.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |